Premium
Surgical treatment for neuroendocrine carcinoma of the uterine cervix
Author(s) -
Kasamatsu T.,
Sasajima Y.,
Onda T.,
Sawada M.,
Kato T.,
Tanikawa M.
Publication year - 2007
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/j.ijgo.2007.06.051
Subject(s) - medicine , parametrium , radical hysterectomy , cervix , lymph node , hysterectomy , surgery , carcinoma , chemotherapy , radiation therapy , cervical cancer , cancer
Objective To identify the best operative approach for neuroendocrine cervical carcinoma (NECC). Methods The records of surgically treated patients with stages IB to IIB NECC were reviewed. Results Of 10 patients who met the study criteria for NECC and underwent radical hysterectomy, 4 had pT1bN0, 4 had pT1bN1, 1 had pT2aN0, and 1 had pT2bN1 disease. Those with pT1bN1 or pT2bN1 disease received postoperative adjuvant radiotherapy and/or chemotherapy, and recurrence occurred in 7 patients (70%). Among these 7 patients, 5 (71%) had a primary NECC tumor with deep stromal invasion and 5 (71%) had extrauterine disease (parametrium and/or lymph node). The recurrences in 6 patients (86%) were located outside the pelvis (lung, liver, or brain). Stromal invasion was 6 mm or less in the 3 patients who did not experience disease recurrence. Conclusions Pelvic control by radical hysterectomy may not be beneficial for patients with NECC except for those with an early invasive lesion.